Atlas Trials

Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

Clinical trial NCT02626520 · TERMINATED

Trial details

NCT number
NCT02626520
Sponsor
Essentia Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ductal Adenocarcinoma of PancreasAdenocarcinoma of Ampulla
Start date
2016-05-11
Primary completion
2016-09-20
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.